Literature DB >> 11159041

Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice.

T Glaab1, A Daser, A Braun, U Neuhaus-Steinmetz, H Fabel, Y Alarie, H Renz.   

Abstract

A method for the noninvasive measurement of airway responsiveness was validated in allergic BALB/c mice. With head-out body plethysmography and the decrease in tidal midexpiratory flow (EF(50)) as an indicator of airway obstruction, responses to inhaled methacholine (MCh) and the allergen ovalbumin were measured in conscious mice. Allergen-sensitized and -challenged mice developed airway hyperresponsiveness as measured by EF(50) to aerosolized MCh compared with that in control animals. This response was associated with increased allergen-specific IgE and IgG1 production, increased levels of interleukin-4 and interleukin-5 in bronchoalveolar lavage fluid and eosinophilic lung inflammation. Ovalbumin aerosol challenge elicited no acute bronchoconstriction but resulted in a significant decline in EF(50) baseline values 24 h after challenge in allergic mice. The decline in EF(50) to MCh challenge correlated closely with simultaneous decreases in pulmonary conductance and dynamic compliance. The decrease in EF(50) was partly inhibited by pretreatment with the inhaled beta(2)-agonist salbutamol. We conclude that measurement of EF(50) to inhaled bronchoconstrictors by head-out body plethysmography is a valid measure of airway hyperresponsiveness in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159041     DOI: 10.1152/ajplung.2001.280.3.L565

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  25 in total

1.  A single DH gene segment is sufficient for the establishment of an asthma phenotype in a murine model of allergic airway inflammation.

Authors:  Sebastian Kerzel; Tobias Rogosch; Julia Wagner; Kathrin Preisser; Ali-Önder Yildirim; Heinz Fehrenbach; Holger Garn; Rolf F Maier; Harry W Schroeder; Michael Zemlin
Journal:  Int Arch Allergy Immunol       Date:  2011-06-29       Impact factor: 2.749

2.  Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma.

Authors:  Sanchaita Sriwal Sonar; Yen-Ming Hsu; Melanie Lynn Conrad; Gerard R Majeau; Ayse Kilic; Ellen Garber; Yan Gao; Chioma Nwankwo; Gundi Willer; Jan C Dudda; Hellen Kim; Véronique Bailly; Axel Pagenstecher; Paul D Rennert; Harald Renz
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

3.  Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice.

Authors:  Jia Wang; Lingwen Kong; Qingli Luo; Bei Li; Jinfeng Wu; Baojun Liu; Xiao Wu; Jingcheng Dong
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2014-06-17       Impact factor: 4.200

5.  Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.

Authors:  S Yamagata; K Tomita; R Sato; A Niwa; H Higashino; Y Tohda
Journal:  Clin Exp Immunol       Date:  2008-09-23       Impact factor: 4.330

6.  Composition of the immunoglobulin classic antigen-binding site regulates allergic airway inflammation in a murine model of experimental asthma.

Authors:  S Kerzel; J Wagner; T Rogosch; A-O Yildirim; L Sikula; H Fehrenbach; H Garn; R F Maier; H W Schroeder; M Zemlin
Journal:  Clin Exp Allergy       Date:  2009-02-03       Impact factor: 5.018

7.  Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation.

Authors:  Armin Braun; Marek Lommatzsch; Ulrich Neuhaus-Steinmetz; David Quarcoo; Thomas Glaab; Gerard P McGregor; Axel Fischer; Harald Renz
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

Review 8.  Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease.

Authors:  Thomas Glaab; Armin Braun
Journal:  Lung       Date:  2021-05-19       Impact factor: 2.584

9.  Comparison of adjuvant and adjuvant-free murine experimental asthma models.

Authors:  M L Conrad; A O Yildirim; S S Sonar; A Kiliç; S Sudowe; M Lunow; R Teich; H Renz; H Garn
Journal:  Clin Exp Allergy       Date:  2009-05-03       Impact factor: 5.018

10.  Attenuated asthma phenotype in mice with a fetal-like antigen receptor repertoire.

Authors:  Regine Stutz; Christopher Meyer; Elisabeth Kaiser; Sybelle Goedicke-Fritz; Harry W Schroeder; Robert Bals; Christoph Haertel; Tobias Rogosch; Sebastian Kerzel; Michael Zemlin
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.